ArticleImmunology2017

Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis.

Stephanie von Kutzleben et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.